Orchid Pharma has acquired 100% global rights to Enmetazobactam, marking a major strategic and national milestone.

• French court approved Orchid's bid to acquire Allecra’s IP, trademarks, and global rights for EXBLIFEP (Orblicef in India).
• This acquisition repatriates India’s first novel antibiotic molecule entirely back to India under Orchid Pharma’s ownership.
• Orchid aims global expansion with consolidated rights, boosting brand value and financial growth in over 40 export markets.